Sign in
4

Changes in Ownership

PRECISION BIOSCIENCES INC Filed Acc 0001209191-21-028105

President and CEO acquired 13,422 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
KANE MATTHEW R. President and CEO 2021-04-21 Option exercise +13,422 $1.18 $15,838 1,978,218 D
Derivatives
KANE MATTHEW R. President and CEO 2021-04-21 Option exercise · Employee Stock Option (Right to Buy) −13,422 0 D
Loading xslF345X03/doc4.xml…